Ziyad Binkhathlan
scholar.google.ca
0000-0003-1853-7490
University of Alberta
19 papers found
Refreshing results…
Design and Development of D‒α‒Tocopheryl Polyethylene Glycol Succinate‒block‒Poly(ε-Caprolactone) (TPGS−b−PCL) Nanocarriers for Solubilization and Controlled Release of Paclitaxel
Pharmacokinetic and Tissue Distribution of Orally Administered Cyclosporine A-Loaded poly(ethylene oxide)-block-Poly(ε-caprolactone) Micelles versus Sandimmune® in Rats
Mitigation of Tacrolimus-Associated Nephrotoxicity by PLGA Nanoparticulate Delivery Following Multiple Dosing to Mice while Maintaining its Immunosuppressive Activity
Treatment of endotoxin-induced uveitis by topical application of cyclosporine a-loaded PolyGel™ in rabbit eyes
Antifungal efficacy of Itraconazole loaded PLGA-nanoparticles stabilized by vitamin-E TPGS: In vitro and ex vivo studies
Effects of block copolymer micelles on the pharmacokinetics of encapsulated drugs
Pharmacokinetics of Orally Administered Poly(Ethylene Oxide)-block-Poly(ε-Caprolactone) Micelles of Cyclosporine A in Rats: Comparison with Neoral®
Toxicity evaluation of methoxy poly(ethylene oxide)- block -poly(ε-caprolactone) polymeric micelles following multiple oral and intraperitoneal administration to rats
Cremophor EL Alters the Plasma Protein Binding and Pharmacokinetic Profile of Valspodar in Rats
Development and characterization of methoxy poly(ethylene oxide)- block -poly(ε-caprolactone) (PEO- b -PCL) micelles as vehicles for the solubilization and delivery of tacrolimus
Reutilization of Tacrolimus Extracted from Expired Prograf® Capsules: Physical, Chemical, and Pharmacological Assessment
P-glycoprotein Inhibition as a Therapeutic Approach for Overcoming Multidrug Resistance in Cancer: Current Status and Future Perspectives
Emerging nanodelivery strategies of RNAi molecules for colon cancer therapy: preclinical developments
Amphiphilic block co-polymers: Preparation and application in nanodrug and gene delivery
Encapsulation of P-glycoprotein inhibitors by polymeric micelles can reduce their pharmacokinetic interactions with doxorubicin
Characterization of the Self Assembly of Methoxy Poly(Ethylene Oxide)-block-Poly(α-Benzyl Carboxylate-ε-Caprolactone) for the Solubilization and In Vivo Delivery of Valspodar
Development of a polymeric micellar formulation for valspodar and assessment of its pharmacokinetics in rat
Pharmacokinetics of PSC 833 (valspodar) in its Cremophor EL formulation in rat
Development of a liquid chromatography–mass spectrometry (LC/MS) assay method for the quantification of PSC 833 (Valspodar) in rat plasma
Missing publications? Search for publications with a matching author name.